210 related articles for article (PubMed ID: 28433619)
1. Lack of pathogenic mutations in SOS1 gene in phenytoin-induced gingival overgrowth patients.
Margiotti K; Pascolini G; Consoli F; Guida V; Di Bonaventura C; Giallonardo AT; Pizzuti A; De Luca A
Arch Oral Biol; 2017 Aug; 80():160-163. PubMed ID: 28433619
[TBL] [Abstract][Full Text] [Related]
2. Lack of mutation in p53 and H-ras genes in phenytoin induced gingival overgrowth suggests its non cancerous nature.
Jayaraman B; Valiathan GM; Jayakumar K; Palaniyandi A; Thenumgal SJ; Ramanathan A
Asian Pac J Cancer Prev; 2012; 13(11):5535-8. PubMed ID: 23317213
[TBL] [Abstract][Full Text] [Related]
3. Increased bFGF level in the serum of patients with phenytoin-induced gingival overgrowth.
Sasaki T; Maita E
J Clin Periodontol; 1998 Jan; 25(1):42-7. PubMed ID: 9477019
[TBL] [Abstract][Full Text] [Related]
4. The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth.
Kamali F; McLaughlin WS; Ball DE; Seymour RA
J Clin Periodontol; 1999 Dec; 26(12):802-5. PubMed ID: 10599907
[TBL] [Abstract][Full Text] [Related]
5. Phenytoin metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) in man, cat and rat in vitro and in vivo, and susceptibility to phenytoin-induced gingival overgrowth.
Kamali F; Ball DE; McLaughlin WS; Seymour RA
J Periodontal Res; 1999 Apr; 34(3):145-53. PubMed ID: 10384402
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue growth factor in drug-induced gingival overgrowth.
Uzel MI; Kantarci A; Hong HH; Uygur C; Sheff MC; Firatli E; Trackman PC
J Periodontol; 2001 Jul; 72(7):921-31. PubMed ID: 11495141
[TBL] [Abstract][Full Text] [Related]
7. Researchers discover gene mutation responsible for hereditary gingival fibromatosis.
Dent Today; 2002 May; 21(5):38-9. PubMed ID: 12026713
[No Abstract] [Full Text] [Related]
8. Phenytoin and gingival mucosa: A molecular investigation.
Candotto V; Pezzetti F; Baj A; Beltramini G; Lauritano D; Di Girolamo M; Cura F
Int J Immunopathol Pharmacol; 2019; 33():2058738419828259. PubMed ID: 31663446
[TBL] [Abstract][Full Text] [Related]
9. Serum phenytoin concentration and IgG antibody titre to periodontal bacteria in patients with phenytoin-induced gingival overgrowth.
Yamada H; Nishimura F; Furuno K; Naruishi K; Kobayashi Y; Takashiba S; Murayama Y
J Int Acad Periodontol; 2001 Apr; 3(2):42-7. PubMed ID: 12666977
[TBL] [Abstract][Full Text] [Related]
10. Folic acid and phenytoin induced gingival overgrowth--is there a preventive effect.
Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P
J Indian Soc Pedod Prev Dent; 2004 Jun; 22(2):82-91. PubMed ID: 15491092
[TBL] [Abstract][Full Text] [Related]
11. Phenytoin-induced gingival overgrowth in un-cooperated epilepsy patients.
Marakoglu I; Gursoy UK; Cakmak H; Marakoglu K
Yonsei Med J; 2004 Apr; 45(2):337-40. PubMed ID: 15119009
[TBL] [Abstract][Full Text] [Related]
12. Gingival overgrowth induced by anticonvulsant drugs: A cross-sectional study on epileptic patients.
Gallo C; Bonvento G; Zagotto G; Mucignat-Caretta C
J Periodontal Res; 2021 Apr; 56(2):363-369. PubMed ID: 33368283
[TBL] [Abstract][Full Text] [Related]
13. Role of nuclear factor kappa-B in phenytoin-induced gingival overgrowth.
Arabaci T; Köse O; Kizildağ A; Albayrak M; Ciçek Y; Kara A
Oral Dis; 2014 Apr; 20(3):294-300. PubMed ID: 23651365
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database.
Bondon-Guitton E; Bagheri H; Montastruc JL
J Clin Periodontol; 2012 Jun; 39(6):513-8. PubMed ID: 22519416
[TBL] [Abstract][Full Text] [Related]
15. Is oral azithromycin effective for the treatment of phenytoin-induced gingival overgrowth in epileptic patients?
Namazi S; Borhani Haghighi A; Karimzadeh I
Med Hypotheses; 2007; 69(5):1159-60. PubMed ID: 17141420
[No Abstract] [Full Text] [Related]
16. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients.
Ball DE; McLaughlin WS; Seymour RA; Kamali F
J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970
[TBL] [Abstract][Full Text] [Related]
17. CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects.
Soga Y; Nishimura F; Ohtsuka Y; Araki H; Iwamoto Y; Naruishi H; Shiomi N; Kobayashi Y; Takashiba S; Shimizu K; Gomita Y; Oka E
Life Sci; 2004 Jan; 74(7):827-34. PubMed ID: 14659971
[TBL] [Abstract][Full Text] [Related]
18. A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1.
Hart TC; Zhang Y; Gorry MC; Hart PS; Cooper M; Marazita ML; Marks JM; Cortelli JR; Pallos D
Am J Hum Genet; 2002 Apr; 70(4):943-54. PubMed ID: 11868160
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive mutation analysis of PIK3CA, p14ARF, p16INK4a and p21Waf1/Cip1 genes is suggestive of a non- neoplastic nature of phenytoin induced gingival overgrowth.
Swamikannu B; Kumar KS; Jayesh RS; Rajendran S; Muthupalani RS; Ramanathan A
Asian Pac J Cancer Prev; 2013; 14(5):2743-6. PubMed ID: 23803025
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced gingival overgrowth after phenytoin and nifedipine therapy. A case report.
Slezák R
J West Soc Periodontol Periodontal Abstr; 1997; 45(4):105-7. PubMed ID: 9571890
[No Abstract] [Full Text] [Related]
[Next] [New Search]
